Delfi Diagnostics Stock

Utilizes artificial intelligence and whole genome sequencing to detect unique patterns of DNA fragmentation in the blood of cancer patients.

Buy

Buy Delfi Diagnostics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Delfi Diagnostics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.

Sector

Health Care

Founded

2019

Headquarters

Palo Alto, CA

Delfi Diagnostics Funding

Delfi Diagnostics Funding History

Sign up to gain insights into Delfi Diagnostics funding history, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series B Jul 18, 2022 225M
XXXXX
XXXXX
Series A Jan 12, 2021 96M
XXXXX
XXXXX
Series Seed Aug 12, 2019 5M
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Delfi Diagnostics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Delfi Diagnostics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Delfi Diagnostics Management Team

Delfi Diagnostics people and management

  • Chief Medical Officer
    Peter Bach
  • Co-founder, Chief Scientific Officer
    Nicholas Dracopoli
  • Board Member
    Grep Yap
  • Board Member
    Jacob S. Van Naarden
  • Board Member
    Justin Kao
  • Board Member
    Liz Homans
  • Board Member
    Mike Dybbs
  • Co-founder, Head of Data Science
    Rob Scharpf
  • CTO
    Amoolya Singh
  • CFO
    Tom Russo
  • CEO, Board Member
    Susan Tousi
  • Founder, Board Member
    Victor Velculescu
  • CFO
    Cindy Soriano
  • Board Member
    Justin Fishner-Wolfson
  • Board Member
    Elizabeth Holmes
  • Board Member
    Paul Walker
  • Board Member
    Michael Dybbs
  • Board Member
    Rishi Gupta

Investors

Major Delfi Diagnostics investors

  • Windham Venture Partners

  • Samsara BioCapital

  • Point72 Ventures

  • Point Field Partners

  • OrbiMed Advisors

  • Open Field Capital

  • Menlo Ventures

  • Illumina

  • Foresite Capital

  • Eli Lilly & Company

  • Draper Fisher Jurvetson (DFJ)

  • Cowen Healthcare Investments

  • AV8 Ventures

Delfi Diagnostics Valuations & Financials

Gain insights Into Delfi Diagnostics Stock Valuation & Share Prices

View real-time NPM data on Delfi Diagnostics stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.

Similar Companies

Explore companies

like Delfi Diagnostics

  • Tonal Strong-Logo

    Tonal

    Health Care

    Delivers AI-powered strength training with digital weights and personalized coaching.

  • Curology-Logo

    Curology

    Health Care

    Offers personalized prescription skin care medications delivered directly to you.

  • Devoted

    Health Care

    Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

  • Cerebral

    Health Care

    Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

  • Virta Health-Logo

    Virta Health

    Health Care

    Online specialty medical clinic focused on reversing type 2 diabetes.

  • Roman Health Ventures-Logo

    Ro

    Health Care

    Healthcare technology for a patient-centric healthcare system.

  • Solugen-Logo

    Solugen

    Materials

    Manufactures biobased solutions that replace chemicals traditionally made using petroleum or natural gas.

  • Generate Biomedicines-Logo

    Generate Biomedicines

    Health Care

    Generative biology company with a revolutionary approach to drug development.

  • Pivot Bio-Logo

    Pivot Bio

    Materials

    Agricultural technology company developing sustainable nitrogen solutions to reduce synthetic fertilizer use and improve crop production efficiency.

FAQ

Questions?

We have answers

Buy Delfi Diagnostics Stock

Delfi Diagnostics stock does not trade on public stock exchanges. Delfi Diagnostics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Delfi Diagnostics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Delfi Diagnostics Stock

Delfi Diagnostics Stock does not trade on public stock exchanges. In order to sell Delfi Diagnostics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Delfi Diagnostics Stock Price

Delfi Diagnostics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Delfi Diagnostics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Delfi Diagnostics Stock Ticker Symbol

There is no ticker symbol for Delfi Diagnostics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Delfi Diagnostics Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Delfi Diagnostics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Delfi Diagnostics Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Delfi Diagnostics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Delfi Diagnostics Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Delfi Diagnostics IPO

Delfi Diagnostics is a private company and has not had an IPO. There is currently no Delfi Diagnostics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Delfi Diagnostics IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.